Julien SCHOPP

Journal articles

2025

ref_biblio

Romane Boyer, Romane Bony, Maxence Maugis, Julien Schopp, Marion Leroux, et al.. LPS2336, a New TREK-1 Channel Activator Identified by High Throughput Screening. Biomolecules, 2025, 15 (5), pp.740. ⟨10.3390/biom15050740⟩. ⟨hal-05167302⟩

Accès au texte intégral et bibtex

2024

ref_biblio

Nicolas Aubert, Madeleine Purcarea, Julien Novarino, Julien Schopp, Alexis Audibert, et al.. Enkephalin-mediated modulation of basal somatic sensitivity by regulatory T cells in mice. eLife, 2024, 13, pp.eLife.91359. ⟨10.7554/eLife.91359⟩. ⟨hal-04678921⟩

Accès au texte intégral et bibtex

ref_biblio

Maxime Barnet, Amelie Descheemaeker, Lea Favier, Xavier Moisset, Julien Schopp, et al.. Estrous cycle regulates cephalic mechanical sensitivity and sensitization of the trigemino-cervical complex in a female rat model of chronic migraine. Pain, 2024, ⟨10.1097/j.pain.0000000000003459⟩. ⟨hal-04803604⟩

Accès au bibtex

ref_biblio

Mélissa Delanne-Cuménal, Sylvain Lamoine, Mathieu Meleine, Youssef Aissouni, Laetitia Prival, et al.. The TREK-1 potassium channel is involved in both the analgesic and anti-proliferative effects of riluzole in bone cancer pain. Biomedicine and Pharmacotherapy, 2024, 176, pp.116887. ⟨10.1016/j.biopha.2024.116887⟩. ⟨hal-04687342⟩

Accès au texte intégral et bibtex

2020

ref_biblio

Jérôme Busserolles, Ismail Ben Soussia, Laetitia Pouchol, Nicolas Marie, Mathieu Meleine, et al.. TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects. British Journal of Pharmacology, 2020, 177 (20), pp.4782-4795. ⟨10.1111/bph.15243⟩. ⟨hal-03512213⟩

Accès au texte intégral et bibtex

Poster communications

2024

ref_biblio

N Aubert, M Purcarea, N Novarino, J Schopp, A Audibert, et al.. Enkephalin-mediated modulation of basal somatic sensitivity by regulatory T cells in mice. 7th European Congress of Immunology, Sep 2024, Dublin, Ireland. ⟨hal-04589310⟩

Accès au bibtex